| Regulatory T‐cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis R Liberal, CR Grant, M Yuksel, J Graham, A Kalbasi, Y Ma, MA Heneghan, ... Hepatology 66 (5), 1570-1584, 2017 | 50 | 2017 |
| T helper cell immunity in pregnancy and influence on autoimmune disease progression JJ Graham, MS Longhi, MA Heneghan Journal of autoimmunity 121, 102651, 2021 | 44 | 2021 |
| Aberrant hepatic trafficking of gut‐derived T cells is not specific to primary sclerosing cholangitis JJ Graham, S Mukherjee, M Yuksel, R Sanabria Mateos, T Si, Z Huang, ... Hepatology 75 (3), 518-530, 2022 | 43 | 2022 |
| Human leukocyte antigen profile predicts severity of autoimmune liver disease in children of European ancestry Y Ma, H Su, M Yuksel, MS Longhi, MJ McPhail, P Wang, S Bansal, ... Hepatology 74 (4), 2032-2046, 2021 | 38 | 2021 |
| Dysfunctional immune regulation in autoimmune hepatitis: from pathogenesis to novel therapies M Vuerich, N Wang, A Kalbasi, JJ Graham, MS Longhi Frontiers in Immunology 12, 746436, 2021 | 27 | 2021 |
| An update on the pharmacological management of autoimmune hepatitis Y Chung, MN Rahim, JJ Graham, Y Zen, MA Heneghan Expert Opinion on Pharmacotherapy 22 (11), 1475-1488, 2021 | 11 | 2021 |
| Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19 N Wang, M Vuerich, A Kalbasi, JJ Graham, E Csizmadia, ZJ Manickas-Hill, ... IScience 24 (10), 2021 | 9 | 2021 |
| Blockade of PGK1 and ALDOA enhances bilirubin control of Th17 cells in Crohn’s disease M Vuerich, N Wang, JJ Graham, L Gao, W Zhang, A Kalbasi, L Zhang, ... Communications Biology 5 (1), 994, 2022 | 8 | 2022 |
| Treg conditioning endows activated teff with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis R Liberal, CR Grant, Y Muhammed, J Graham, A Kalbasi, Y Ma, ... Hepatology (Baltimore, Md.) 66 (5), 1570, 2017 | 5 | 2017 |
| vedolizumab for autoimmune liver disease associated inflammatory bowel disease P Pavlidis, J Graham, S Gulati, P Dubois, M Heneghan, D Joshi, B Hayee Alimentary Pharmacology & Therapeutics 47 (10), 1422-1423, 2018 | 2 | 2018 |
| Soluble MAdCAM-1 as a novel marker of hepatic endothelial dysfunction in acutely decompensated cirrhosis J Graham, F Trovato, D Erminelli, X Huang, R Liberal, D Vergani, ... endothelium (MAdCAM-1 in chronic inflammatory liver disease) 33 (5), 1065-72, 2001 | 2 | 2001 |
| Silencing of aryl hydrocarbon receptor repressor modulates Th17-cell immunity in human autoimmune hepatitis MS Longhi, L Gao, W Zhang, L Zhang, S Nastasio, JJ Graham, A Bonder, ... The Journal of Immunology 210 (1_Supplement), 155.16-155.16, 2023 | | 2023 |
| Selective inhibition of estrogen receptor alpha restores regulatory T-cell function in autoimmune hepatitis MS Longhi, JJ Graham, L Gao, W Zhang, L Zhang, S Nastasio, A Kalbasi, ... The Journal of Immunology 210 (1_Supplement), 155.17-155.17, 2023 | | 2023 |
| SELECTIVE INHIBITION OF ESTROGEN RECEPTOR ALPHA RESTORES REGULATORY T CELL FUNCTION IN AUTOIMMUNE HEPATITIS J Graham, L Gao, W Zhang, A Kalbasi, A Bonder, V Patwardhan, ... HEPATOLOGY 76, S1472-S1472, 2022 | | 2022 |
| Transcriptome profiling of PBMCs and formalin-fixed autopsy tissues from COVID-19 patients M Vuerich, N Wang, A Kalbasi, JJ Graham, MS Longhi STAR protocols 3 (1), 101156, 2022 | | 2022 |
| SELECTIVE INHIBITION OF ESTROGEN RECEPTOR ALPHA RESTORES REGULATORY T CELL FUNCTIONAL PHENOTYPE IN AUTOIMMUNE HEPATITIS J Graham, N Wang, A Kalbasi, A Bonder, V Patwardhan, SC Robson, ... HEPATOLOGY 74 (6), 1397A-1397A, 2021 | | 2021 |
| THE IMPACT OF PREGNANCY IN PATIENTS WITH AUTOIMMUNE HEPATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS T Si, Z Huang, J Graham, Y Ma, MA Heneghan The Liver Meeting Digital Experience™, 2020 | | 2020 |
| T lymphocyte trafficking in the pathogenesis of autoimmune liver disease with associated inflammatory bowel disease J Graham King's College London, 2020 | | 2020 |
| HEPATIC MADCAM-1 EXPRESSION IS A PAN-AETIOLOGICAL FEATURE OF DECOMPENSATED CIRRHOSIS ASSOCIATED WITH INFILTRATION OF PRO-INFLAMMATORY GUT-DERIVED T LYMPHOCYTES J Graham, S Mukherjee, R Liberal, D Vergani, G Mieli-Vergani, Y Ma, ... HEPATOLOGY 70, 811A-811A, 2019 | | 2019 |
| INFLAMMATORY BOWEL DISEASE (IBD) IN PATIENTS WITH AUTOIMMUNE SCLEROSING CHOLANGITIS COMMONLY REQUIRES ESCALATION OF IBD THERAPY HOWEVER CO-EXISTENT IBD DOES NOT AFFECT LIVER … J Nayagam, O Mandour, J Graham, B Hayee, P Dubois, I Bjarnason, ... HEPATOLOGY 70, 861A-861A, 2019 | | 2019 |
